Fig. 5: Representative chest X-ray images.
From: Efficacy and tolerability of bevacizumab in patients with severe Covid-19
Chest X-ray images of an Italian patient with severe Covid-19 who received bevacizumab treatment at days 0 (a), 3 (b), and 7 (c) relative to the prior treatment baseline.
